These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 10590068)
1. The BCR/ABL oncogene alters the chemotactic response to stromal-derived factor-1alpha. Salgia R; Quackenbush E; Lin J; Souchkova N; Sattler M; Ewaniuk DS; Klucher KM; Daley GQ; Kraeft SK; Sackstein R; Alyea EP; von Andrian UH; Chen LB; Gutierrez-Ramos JC; Pendergast AM; Griffin JD Blood; 1999 Dec; 94(12):4233-46. PubMed ID: 10590068 [TBL] [Abstract][Full Text] [Related]
2. p210(Bcr-Abl) desensitizes Cdc42 GTPase signaling for SDF-1alpha-directed migration in chronic myeloid leukemia cells. Chang YC; Tien SC; Tien HF; Zhang H; Bokoch GM; Chang ZF Oncogene; 2009 Nov; 28(46):4105-15. PubMed ID: 19718053 [TBL] [Abstract][Full Text] [Related]
3. Differential effect of leukaemogenic tyrosine kinases on cell motility is governed by subcellular localisation. Pierce A; Lu Y; Hamzah HG; Thompson S; Owen-Lynch PJ; Whetton AD; Spooncer E Br J Haematol; 2006 May; 133(3):345-52. PubMed ID: 16643438 [TBL] [Abstract][Full Text] [Related]
4. Biological effects of stroma-derived factor-1 alpha on normal and CML CD34+ haemopoietic cells. Dürig J; Rosenthal C; Elmaagacli A; Heyworth C; Halfmeyer K; Kasper C; Novotny J; Dührsen U Leukemia; 2000 Sep; 14(9):1652-60. PubMed ID: 10995013 [TBL] [Abstract][Full Text] [Related]
5. The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1. Möhle R; Bautz F; Rafii S; Moore MA; Brugger W; Kanz L Blood; 1998 Jun; 91(12):4523-30. PubMed ID: 9616148 [TBL] [Abstract][Full Text] [Related]
6. p210BCR-ABL inhibits SDF-1 chemotactic response via alteration of CXCR4 signaling and down-regulation of CXCR4 expression. Geay JF; Buet D; Zhang Y; Foudi A; Jarrier P; Berthebaud M; Turhan AG; Vainchenker W; Louache F Cancer Res; 2005 Apr; 65(7):2676-83. PubMed ID: 15805265 [TBL] [Abstract][Full Text] [Related]
7. Effect of mutational inactivation of tyrosine kinase activity on BCR/ABL-induced abnormalities in cell growth and adhesion in human hematopoietic progenitors. Ramaraj P; Singh H; Niu N; Chu S; Holtz M; Yee JK; Bhatia R Cancer Res; 2004 Aug; 64(15):5322-31. PubMed ID: 15289338 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of class II phosphoinositide 3-kinase gamma expression by p185(Bcr-Abl) contributes to impaired chemotaxis and aberrant homing of leukemic cells. Yu W; Sun X; Tang H; Tao Y; Dai Z Leuk Lymphoma; 2010 Jun; 51(6):1098-107. PubMed ID: 20536348 [TBL] [Abstract][Full Text] [Related]
10. Crosstalk between BCR/ABL oncoprotein and CXCR4 signaling through a Src family kinase in human leukemia cells. Ptasznik A; Urbanowska E; Chinta S; Costa MA; Katz BA; Stanislaus MA; Demir G; Linnekin D; Pan ZK; Gewirtz AM J Exp Med; 2002 Sep; 196(5):667-78. PubMed ID: 12208881 [TBL] [Abstract][Full Text] [Related]
11. Rapid generation of a tetracycline-inducible BCR-ABL defective retrovirus using a single autoregulatory retroviral cassette. Dugray A; Geay JF; Foudi A; Bonnet ML; Vainchenker W; Wendling F; Louache F; Turhan AG Leukemia; 2001 Oct; 15(10):1658-62. PubMed ID: 11587226 [TBL] [Abstract][Full Text] [Related]
12. Immature leukemic CD34+CXCR4+ cells from CML patients have lower integrin-dependent migration and adhesion in response to the chemokine SDF-1. Peled A; Hardan I; Trakhtenbrot L; Gur E; Magid M; Darash-Yahana M; Cohen N; Grabovsky V; Franitza S; Kollet O; Lider O; Alon R; Rechavi G; Lapidot T Stem Cells; 2002; 20(3):259-66. PubMed ID: 12004084 [TBL] [Abstract][Full Text] [Related]
13. Administration of a plasmid that expresses SDF-1α affects the oncogenic potential of mouse bcr-abl-transformed cells. Lucansky V; Krmencikova-Fliegl M; Stanek L; Vonka V Mol Med Rep; 2014 Oct; 10(4):2116-22. PubMed ID: 25070183 [TBL] [Abstract][Full Text] [Related]
14. Mechanism of resistance to the ABL tyrosine kinase inhibitor STI571 in BCR/ABL-transformed hematopoietic cell lines. Weisberg E; Griffin JD Blood; 2000 Jun; 95(11):3498-505. PubMed ID: 10828035 [TBL] [Abstract][Full Text] [Related]
15. In vitro behavior of hematopoietic progenitor cells under the influence of chemoattractants: stromal cell-derived factor-1, steel factor, and the bone marrow environment. Kim CH; Broxmeyer HE Blood; 1998 Jan; 91(1):100-10. PubMed ID: 9414273 [TBL] [Abstract][Full Text] [Related]
17. Janus kinase 2 is involved in stromal cell-derived factor-1alpha-induced tyrosine phosphorylation of focal adhesion proteins and migration of hematopoietic progenitor cells. Zhang XF; Wang JF; Matczak E; Proper JA; Groopman JE Blood; 2001 Jun; 97(11):3342-8. PubMed ID: 11369622 [TBL] [Abstract][Full Text] [Related]
18. A model of human p210(bcr/ABL)-mediated chronic myelogenous leukemia by transduction of primary normal human CD34(+) cells with a BCR/ABL-containing retroviral vector. Zhao RC; Jiang Y; Verfaillie CM Blood; 2001 Apr; 97(8):2406-12. PubMed ID: 11290604 [TBL] [Abstract][Full Text] [Related]
19. The BCR/ABL tyrosine kinase induces production of reactive oxygen species in hematopoietic cells. Sattler M; Verma S; Shrikhande G; Byrne CH; Pride YB; Winkler T; Greenfield EA; Salgia R; Griffin JD J Biol Chem; 2000 Aug; 275(32):24273-8. PubMed ID: 10833515 [TBL] [Abstract][Full Text] [Related]
20. Flt3 ligand and the Flt3 receptor regulate hematopoietic cell migration by modulating the SDF-1alpha(CXCL12)/CXCR4 axis. Fukuda S; Broxmeyer HE; Pelus LM Blood; 2005 Apr; 105(8):3117-26. PubMed ID: 15618475 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]